8:00 am Registration & Coffee

8:55 am Opening Remarks & Day 1 Summary

Clinical Trial Case Studies
Gain invaluable insights on the most advanced clinical programs to discover how the application of allogeneic cell therapies are being successfully utilized in the clinic.

9:00 am Assessing the Efficacy & Safety of Allogeneic Osteoblastic Cells (ALLOB) Single Implantation in Tibial Fracture

9:30 am Allogeneic, Off-the-Shelf T-Cell Immunotherapy Cell Therapies & Derivation of a Next- Generation CAR-T Platform

  • Blake Aftab VP, Preclinical & Translational Science, Atara Biotherapeutics

10:00 am Learnings from Allogeneic CAR-T Clinical Trials

10:30 am Genetically Engineered Allogeneic NK Cell lines for Treatment of Cancer & Viral Infections

11:00 am Tech Slam

11:30 am Morning Refreshments & Networking

12:30 pm How to Commercially Scale T-cell Allogeneic Therapies

1:30 pm Lunch & Networking

2:30 pm Protecting Allogeneic Effector Cells from Host Immune Rejection

3:00 pm Organoids to Test Strategies to Avoid Allo-Recognition

  • Matthias Von Herrath Vice President and Senior Medical Officer, Global Chief Medical Office , Novo Nordisk

3:30 pm Afternoon Refreshments & Networking

4:00 pm Developing Allogeneic CRISPR-Based Cell Therapies Using a Proprietary Gene Editing System (GEMS)

  • Sicco Popma CEO, President & Founder IO , Biosciences

4:30 pm Close of Summit